首页> 外文期刊>Clinical proteomics. >Quantitative tandem mass-spectrometry of skin tissue reveals putative psoriatic arthritis biomarkers
【24h】

Quantitative tandem mass-spectrometry of skin tissue reveals putative psoriatic arthritis biomarkers

机译:皮肤组织的定量串联质谱分析揭示了假定的银屑病关节炎生物标志物

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Psoriatic arthritis (PsA) is a distinct inflammatory arthritis occurring in 30% of psoriasis patients. There is a high prevalence of undiagnosed PsA in psoriasis patients; therefore, identifying soluble biomarkers for PsA could help in screening psoriasis patients for appropriate referral to a rheumatologist. Potential PsA biomarkers likely originate in sites of inflammation, such as the skin, and subsequently enter systemic circulation. Our goal was to identify candidate PsA biomarkers by comparing the proteome of skin biopsies obtained from patients with PsA to that from patients with psoriasis without PsA.Methods: Skin biopsies were obtained from involved and uninvolved skin of 10 PsA and 10 age/gender-matched psoriasis patients without PsA (PsC). Using strong cation exchange chromatography, followed by label-free quantitative tandem mass spectrometry, we characterized the proteomes of pooled skin samples. Extracted ion current intensities were used to calculate protein abundance ratios, and these were utilized to identify differentially regulated proteins.Results: Forty-seven proteins were elevated in PsA-derived skin compared to PsC-derived skin. Selected reaction monitoring assays were developed to quantify these potential PsA markers in individual skin samples, and 8 markers were confirmed in an independent sample set. ITGB5 and POSTN were measured in serum samples from 33 PsA and 15 PsC patients, using enzyme-linked immunosorbent assays. ITGB5 was significantly elevated in PsA serum (P < 0.01), and POSTN showed a trend. ITGB5 and POSTN correlated significantly in both patient groups (r = 0.472, P < 0.001).Conclusion: Proteomic analysis of PsA and PsC skin identified eight new candidate biomarkers. These markers need to be validated with a larger and independent cohort, in order to delineate their clinical utility in PsA patients. These proteins may also uncover unknown aspects of PsA pathobiology.
机译:背景:银屑病关节炎(PsA)是一种独特的炎性关节炎,发生在30%的牛皮癣患者中。牛皮癣患者中未诊断出的PsA患病率很高;因此,鉴定PsA的可溶性生物标记物可以帮助筛选牛皮癣患者,以便适当地转诊至风湿病学家。潜在的PsA生物标记物可能起源于炎症部位,例如皮肤,随后进入全身循环。我们的目标是通过比较从PsA患者和没有PsA的牛皮癣患者获得的皮肤活检蛋白质组来鉴定候选PsA生物标记物。方法:从10例PsA和10个年龄/性别匹配的受累和未受累皮肤中获得皮肤活检。没有PsA(PsC)的牛皮癣患者。使用强阳离子交换色谱,然后进行无标记定量串联质谱分析,我们表征了合并的皮肤样品的蛋白质组。提取的离子电流强度用于计算蛋白质丰度比,并用于鉴定差异调节的蛋白质。结果:与PsC来源的皮肤相比,PsA来源的皮肤中有47种蛋白质升高。开发了选择的反应监测测定法以定量单个皮肤样品中的这些潜在PsA标记,并在独立的样品集中确认了8个标记。使用酶联免疫吸附测定法从33名PsA和15名PsC患者的血清样本中测量ITGB5和POSTN。 PGB血清中ITGB5显着升高(P <0.01),POSTN呈趋势。在两个患者组中,ITGB5和POSTN显着相关(r = 0.472,P <0.001)。结论:PsA和PsC皮肤的蛋白质组学分析确定了八个新的候选生物标志物。这些标志物需要通过更大且独立的队列进行验证,以描述其在PsA患者中的临床应用。这些蛋白质也可能揭示PsA病理生物学的未知方面。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号